| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| EXELIXIS, INC. | Director | Common Stock | 37K | $768K | $20.76 | May 31, 2024 | Direct |
| OptiNose, Inc. | Director | Stock Option (Right to Buy) | 75K | Jun 6, 2024 | Direct | ||
| Invivyd, Inc. | Director | Stock Option (Right to Buy) | 50K | May 23, 2023 | Direct | ||
| Akero Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 26K | Jun 8, 2024 | Direct | ||
| Xilio Therapeutics, Inc. | Director | Stock Option (right to buy) | 13.2K | Jun 12, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | Jun 8, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
| OPTN | OptiNose, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| EXEL | EXELIXIS, INC. | May 31, 2024 | 1 | $0 | 4 | Jun 4, 2024 | Director |
| AKRO | Akero Therapeutics, Inc. | Jun 23, 2023 | 1 | $0 | 4 | Jun 27, 2023 | Director |
| AKRO | Akero Therapeutics, Inc. | Jun 16, 2023 | 3 | -$770K | 4 | Jun 21, 2023 | Director |
| XLO | Xilio Therapeutics, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
| OPTN | OptiNose, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
| EXEL | EXELIXIS, INC. | May 31, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director |
| EXEL | EXELIXIS, INC. | May 31, 2023 | 0 | $0 | 3 | Jun 2, 2023 | Director |
| IVVD | Invivyd, Inc. | May 23, 2023 | 1 | $0 | 4 | May 25, 2023 | Director |
| XLO | Xilio Therapeutics, Inc. | Sep 15, 2022 | 0 | $0 | 3 | Sep 16, 2022 | Director |
| XLO | Xilio Therapeutics, Inc. | Sep 15, 2022 | 1 | $0 | 4 | Sep 16, 2022 | Director |
| IVVD | Adagio Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
| OPTN | OptiNose, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 9, 2022 | Director |
| AKRO | Akero Therapeutics, Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
| IVVD | Adagio Therapeutics, Inc. | Aug 5, 2021 | 0 | $0 | 3 | Aug 5, 2021 | Director |
| OPTN | OptiNose, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
| AKRO | Akero Therapeutics, Inc. | Jun 1, 2021 | 1 | $0 | 4 | Jun 3, 2021 | Director |